Table 4.
Binding Affinities (Kcal/mol) from 1-Click Docking between Conventional Ligands and Oil Blend Compounds Targeting Ki-67.
| Ligand | Target Molecule |
Molecular Affinity (Kcal/mol) |
|---|---|---|
| Cisplatin | Ki-67 | -3.3 |
| Paclitaxel | Ki-67 | -2.9 |
| Bevacizumab | Ki-67 | -3.6 |
| Pembrolizumab | Ki-67 | -4.2 |
| Topotecan | Ki-67 | -5.5 |
| Curcumin | Ki-67 | -5.3 |
| Resveratrol | Ki-67 | -7.7 |
| Epigallocatechin gallate | Ki-67 | -8.6 |
| Olaparib | Ki-67 | -6.9 |
| Everolimus | Ki-67 | -4.9 |
| Temsirolimus | Ki-67 | -6.7 |
| Oleic Acid | Ki-67 | -4.9 |
| g-Tocopherol | Ki-67 | -7.7 |
| Sitosterol | Ki-67 | -7.9 |
| quercetin 3-O-glucoside | Ki-67 | -9.1 |
| apigenin 5-O-glucoside | Ki-67 | -8.8 |
| kaempferol 3-O-glycoside | Ki-67 | -6.4 |
| Eugenol | Ki-67 | -8.1 |
| Eugenyl Acetate | Ki-67 | -8.1 |
| b-Caryophillene | Ki-67 | -7.5 |